Some breast implants shown to cause large-cell lymphoma

Breast enhancement surgery is a procedure conducted all over the world. . Some do it because they want to feel more confident about their appearance, while others do it as part of reconstruction after breast cancer. Whichever it is, studies show the procedure comes with the risk to developing complications.

Recently, the FDA published a report linking a rare lymphoma to breast implants. There have been 359 reported cases globally, taking the lives of 9 women.

It is called anaplastic large-cell lymphoma, and the FDA confirmed it can develop following breast implant surgery.

“This is a type of lymphoma. It is not a breast cancer. It’s actually a cancer that develops in the scar tissue around a breast implant,” said Dr. Mark Clemens.

The American Society of Plastic Surgeons says around 550,000 women last year received breast implants. As of now the risk is fairly low, but one in 30,000 women with implants could develop the rare lymphoma.

Women can choose between a smooth or a textured outer surface for their implants. Rougher textured implants are used to limit the movement of a breast implant.

In the U.S. about 15 percent of implants are textured. The FDA reported that vast majority of women who developed the lymphoma received the textured implants.

The lymphoma has a high-cure rate, and it can easily be treated by removing the implants as soon as possible. The cost of removal and reconstruction is estimated at $9,000 to $12,000.

The report says women with implants should seek medical assistance if they see changes in the implants or breasts, such as painful swelling or lumps.

To see more stories like this, sign up below for Dennis Michael Lynch’s email newsletter.







 

Comment via Facebook

Send this to a friend